Person

Perry C. Siatis

EVP, GC AND SECRETARY, AbbVie

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$24.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 2, 2026ABBVSale10,291$234.66$2.4M
Mar 2, 2026ABBVSale2,600$235.26$612K
Mar 2, 2026ABBVSale5,777$233.51$1.3M
Feb 25, 2026ABBVSale22,381$230.00$5.1M
Mar 3, 2025ABBVSale18,008$210.00$3.8M
Feb 28, 2025ABBVSale6,811$206.62$1.4M
Feb 28, 2025ABBVSale363$207.19$75K
Feb 28, 2025ABBVSale2,718$205.38$558K
Feb 20, 2025ABBVSale3,994$198.12$791K
Feb 20, 2025ABBVSale1,784$197.40$352K
Feb 29, 2024ABBVSale3,387$178.04$603K
Feb 29, 2024ABBVSale6,504$177.05$1.2M
Feb 23, 2024ABBVSale13,753$177.51$2.4M
Apr 3, 2023ABBVSale3,520$160.00$563K
Mar 1, 2023ABBVSale11,330$153.06$1.7M
Mar 1, 2023ABBVSale805$153.38$123K
Feb 21, 2023ABBVSale3,431$150.73$517K
Feb 21, 2023ABBVSale3,933$151.29$595K

SEC reporting-owner ID (CIK) 1951400 · all filings on EDGAR

Perry C. Siatis (ABBV) | USBoard